Evidence map›Paper›PMID 30518652›Full record

ArticleJournal of virology2019

Spatiotemporal Differences in Presentation of CD8 T Cell Epitopes during Hepatitis B Virus Infection.

Atefeh Khakpoor, Yi Ni, Antony Chen, Zi Zong Ho, Vincent Oei, Ninghan Yang, Reshmi Giri, Jia Xin Chow, Anthony T Tan, Patrick T Kennedy and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Restoring, releasing or replacing adaptive immunity in chronic hepatitis B.Nature reviews. Gastroenterology & hepatology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 4 countries.

Atefeh KhakpoorEmerging Infectious Diseases Program, Duke-NUS Medical School, Singapore, Republic of Singapore.
Yi NiDepartment of Infectious Diseases, Molecular Virology, University Hospital Heidelberg, Heidelberg, Baden-Württemberg, Germany.
Antony ChenInfectious Disease and Vaccines, Janssen Pharmaceuticals, Beerse, Belgium.
Zi Zong HoLion TCR Private Limited, Singapore, Republic of Singapore.
Vincent OeiEmerging Infectious Diseases Program, Duke-NUS Medical School, Singapore, Republic of Singapore.
Ninghan YangSingapore Immunology Network, A*STAR, Singapore, Republic of Singapore.
Reshmi GiriEmerging Infectious Diseases Program, Duke-NUS Medical School, Singapore, Republic of Singapore.
Jia Xin ChowEmerging Infectious Diseases Program, Duke-NUS Medical School, Singapore, Republic of Singapore.
Anthony T TanEmerging Infectious Diseases Program, Duke-NUS Medical School, Singapore, Republic of Singapore.
Patrick T KennedyHepatology, Centre for Immunobiology, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Mala MainiDivision of Infection and Immunity, University College London, London, United Kingdom.
Stephan UrbanDepartment of Infectious Diseases, Molecular Virology, University Hospital Heidelberg, Heidelberg, Baden-Württemberg, Germany.
Antonio BertolettiEmerging Infectious Diseases Program, Duke-NUS Medical School, Singapore, Republic of Singapore antonio@duke-nus.edu.sg.
Duke-NUS Medical School · SGGerman Center for Infection Research · DEAgency for Science, Technology and Research · SGJanssen (Belgium) · BEQueen Mary University of London · GBUniversity College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Distinct populations of hepatocytes infected with hepatitis B virus (HBV) or only harboring HBV DNA integrations coexist within an HBV chronically infected liver. These hepatocytes express HBV antigens at different levels and with different intracellular localizations, but it is not known whether this heterogeneity of viral antigen expression could result in an uneven hepatic presentation of distinct HBV epitopes/HLA class I complexes triggering different levels of activation of HBV-specific CD8

Indexed as

CD8-Positive T-LymphocytesEpitopesEpitopes, T-LymphocyteHepatitis BHepatitis B Core AntigensHepatitis B virusHep G2 CellsHumansInterferon-gammaLiverSpatio-Temporal AnalysisEpitopesEpitopes, T-LymphocyteHepatitis B Core AntigensInterferon-gammaantigen presentationCD8+ T cellschronic hepatitis B patientHBV DNA integrationhepatitis B virusHLA class Iliver

Identifiers

PMID30518652
PMCPMC6364024
OpenAlexW2902997251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.